Search results
Earnings call: Jazz Pharmaceuticals sustains growth with key drivers By Investing.com
Investing.com· 2 hours agoJazz Pharmaceuticals PLC (NASDAQ:JAZZ) has reported robust first-quarter 2024 results, showcasing...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Holdings Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 21 hours agoRussell Investments Group Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 84.5% during the fourth quarter, according ...
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
FOX 59 Indianapolis· 17 hours agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Global Health Care Conference ...
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195.08
ETF DAILY NEWS· 1 day agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings ...
Q1 2024 Jazz Pharmaceuticals PLC Earnings Call Transcript
Guru Focus· 17 hours agoMay 01, 2024 / 08:30PM GMTOperator Thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to wel
Jazz: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 17 hours agoDUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Wednesday reported a loss of $14.6 million in its first quarter. The Dublin-based company ...
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 14 hours agoThe headline numbers for Jazz (JAZZ) give insight into how the company performed in the quarter...
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks via Yahoo Finance· 7 days agoArdelyx (ARDX) doesn't possess the right combination of the two key ingredients for a likely...
Sweet Harmony: Neuro biotech buys Epygenix and its epilepsy meds for $35M upfront
FierceBiotech· 2 days agoHarmony Biosciences is adding a suite of epilepsy assets to its pipeline, buying Epygenix for $35 million upfront with more than $600 million in biobucks on the table. The relatively small M ...
Breakthrough study on post-traumatic stress disorder
UC Newsroom· 7 days agoThe consortium’s database was assembled from various sources, representing a variety of causes and levels of trauma. Nievergelt said the sources included...
